tetrabenazine has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohnen, NI; Chou, KL; Gilman, S | 1 |
| Frey, KA; Gilman, S; Jewett, DM; Junck, L; Kilbourn, MR; Koeppe, RA; Lee, LC; Little, R; Lohman, M; Martorello, S; Vander Borght, TM | 1 |
2 other study(ies) available for tetrabenazine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Association between autonomic dysfunction and fatigue in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Surveys and Questionnaires; Tetrabenazine | 2017 |
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Biological Transport; Cerebellar Diseases; Corpus Striatum; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Olivopontocerebellar Atrophies; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1996 |